Elkfork Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$742K Sell
2,728
-198
-7% -$55.1K 0.02% 466
2019
Q2
$806K Sell
2,926
-1,914
-40% -$472K 0.02% 447
2019
Q1
$1.08M Buy
4,840
+506
+12% +$104K 0.03% 360
2018
Q4
$806K Buy
4,334
+990
+30% +$203K 0.02% 392
2018
Q3
$835K Sell
3,344
-264
-7% -$64.1K 0.02% 430
2018
Q2
$786K Sell
3,608
-418
-10% -$86.1K 0.02% 401
2018
Q1
$770K Sell
4,026
-1,760
-30% -$325K 0.02% 404
2017
Q4
$905K Sell
5,786
-4,334
-43% -$682K 0.02% 382
2017
Q3
$1.57M Buy
10,120
+792
+8% +$125K 0.05% 271
2017
Q2
$1.51M Buy
9,328
+4,224
+83% +$686K 0.05% 269
2017
Q1
$789K Buy
5,104
+1,056
+26% +$146K 0.02% 348
2016
Q4
$475K Buy
+4,048
New +$462K 0.02% 423

Other funds holding IDXX

Elkfork Partners's IDXX Position: Q3 2019 in Review

Elkfork Partners reduced its Idexx Laboratories (IDXX) stake by 6.8% in Q3 2019, selling an estimated $55.1K and leaving 2,728 shares worth $742K. The position accounts for 0.02% of the portfolio, ranked #466.

Elkfork Partners first reported a position in IDXX in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.57M in Q3 2017. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

  • Elkfork Partners held 2,728 shares of Idexx Laboratories worth $742K as of Q3 2019.
  • Elkfork Partners sold 198 Idexx Laboratories shares in Q3 2019, an estimated $55.1K.
  • Idexx Laboratories made up 0.02% of Elkfork Partners's portfolio in Q3 2019, its #466 holding.
  • Elkfork Partners first reported a position in Idexx Laboratories in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Idexx Laboratories position peaked at $1.57M in Q3 2017.
  • 720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.